Abstract Background In Europe cardiovascular disease (CVD) is responsible for 3.9 million
deaths (45% of deaths), being ischaemic heart disease, stroke, hypertension (leading to …

Glucagon like peptide-1 (GLP-1) is an incretin secretory molecule. GLP-1 receptor agonists
(GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their …

Cancer immunotherapy targeting co-inhibitory pathways by checkpoint blockade shows
remarkable efficacy in a variety of cancer types. However, only a minority of patients respond …

Urbanization is one of the major transformations, along with industrialization and economic
development, profoundly impacting human society and its living environment. Among the …

Air pollution is well recognized as a major risk factor for chronic non-communicable
diseases and has been estimated to contribute more to global morbidity and mortality than …

Cardiovascular disease (CVD) is the leading cause of death in Asia. To combat the harmful
impacts of CVD on public health in Asian countries with more effective strategies and …

Summary Each year, the American Heart Association (AHA), in conjunction with the National
Institutes of Health and other government agencies, brings together in a single document the …

Telemedicine allows the remote exchange of medical data between patients and healthcare
professionals. It is used to increase patients' access to care and provide effective healthcare …

Despite extensive evidence showing that exposure to specific chemicals can lead to
disease, current research approaches and regulatory policies fail to address the chemical …

Aims Ambient air pollution is a major health risk, leading to respiratory and cardiovascular
mortality. A recent Global Exposure Mortality Model, based on an unmatched number of …